ワルファリン市場 - 2031 年の成長予測、統計および事実

  • Report Code : TIPRE00023279
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

市場概要 ワルファリン (抗凝血剤としても知られています) は、血液凝固を予防または軽減し、血液凝固時間を延長する化学物質です。これらの薬剤は主に、心房細動、深部静脈血栓症、心筋梗塞、肺塞栓症、脳卒中など、さまざまな病状における血栓のリスクが高い場合に使用されます。ワルファリンは、血栓の形成を制御および防止することにより、人間の心臓血管の健康を保護する上で重要な役割を果たします。 市場範囲 「2031年までの世界ワルファリン市場分析」は、世界市場動向分析に特に焦点を当てた、製薬業界の専門的かつ詳細な調査です。このレポートは、投与経路、適用、地理ごとに詳細な市場分割を行い、ワルファリン市場の概要を提供することを目的としています。このレポートは、ワルファリン市場の主要プレーヤーの市場状況に関する主要な統計を提供し、市場の主要な傾向と機会を提供します。 市場セグメンテーション
    • 世界のワルファリン市場は、投与経路に基づいて、経口ワルファリンと静脈内ワルファリンに分割されます。 • アプリケーションに基づいて、市場は心房細動と心臓発作、脳卒中、深部静脈血栓症(dvt)、肺塞栓症(pe)などに分類されます。
市場力学 要因
    • 静脈血栓塞栓症(VTE)および心血管障害の有病率の上昇。 • 肥満人口と高齢者人口の増加。 • 新規経口抗凝固薬(NOAC)の受け入れの増加。 • 発展途上地域における NOAC に対する意識の高まり。
制約
    • NOAC のコスト高と NOAC に対する解毒剤の不足が、この市場の主な制約要因となっています。
このレポートは、定性的情報と定量的情報の両方を含む業界の詳細な概要を提供します。さまざまなセグメントに基づいた世界市場の概要と予測を提供します。また、次の 5 つの主要地域に関して、2021 年から 2031 年までの市場規模と予測推定値も提供します。北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、南米。各地域別のワルファリン市場は、後にそれぞれの国とセグメントごとにサブセグメント化されます。このレポートでは、世界 18 か国の分析と予測、およびこの地域に広がる現在の傾向と機会について取り上げています。レポートは、需要と供給の両方の側面から市場に影響を与える要因を分析し、予測期間中に市場に影響を与える市場のダイナミクス、つまり推進力、制約、機会、将来の傾向をさらに評価します。このレポートは、5 つの地域すべてに対する徹底的な PEST 分析も提供します。北米、ヨーロッパ、APAC、MEA、および南米。これらの地域のワルファリン市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後。ワルファリン市場に対する 新型コロナウイルス感染症(COVID-19) の影響 新型コロナウイルス感染症(COVID-19)は、2021 年 12 月に初めて武漢(中国)で発生し、それ以来、速いペースで世界中に広がりました。米国、インド、ブラジル、ロシア、フランス、英国、トルコ、イタリア、スペインは、感染者数と死亡報告数で最も深刻な影響を受けている国の一部です。新型コロナウイルス感染症は、ロックダウン、渡航禁止、事業停止などにより、さまざまな国の経済や産業に影響を与えています。さまざまな工場や工場の閉鎖は世界のサプライチェーンに影響を及ぼし、世界市場での製品の製造、納期スケジュール、販売に悪影響を及ぼしています。製品納期の遅延や自社製品の将来の売上不振の可能性をすでに発表している企業はほとんどない。これに加えて、ヨーロッパ、アジア太平洋、北米の国々によって課された世界的な渡航禁止措置が、ビジネスコラボレーションやパートナーシップの機会に影響を与えています。 市場関係者 このレポートは、有機的および無機的な成長戦略としてワルファリン市場の主要な動向をカバーしています。さまざまな企業が、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に焦点を当てています。市場で目撃された無機質な成長戦略活動は、買収、パートナーシップ、コラボレーションでした。これらの活動により、市場プレーヤーのビジネスと顧客ベースの拡大への道が開かれました。ワルファリン市場からの市場支払者は、世界市場でのワルファリンの需要の高まりに伴い、将来的に有利な成長機会が期待されています。レポートには、ワルファリン市場における主要企業のSWOT分析と市場戦略とともにプロフィールも含まれています。さらに、このレポートは業界の主要企業に焦点を当てており、企業概要、提供されるコンポーネント、サービス、過去 3 年間の財務情報、過去 5 年間の主要な開発などの情報を提供します。
    • アスペン ホールディングス • バイエル AG • ベーリンガーインゲルハイム GmbH • ブリストル マイヤーズ スクイブ カンパニー • 第一三共株式会社 • GlaxoSmithKline plc. • Johnson & Johnson (Janssen Pharmaceuticals, Inc.) • Pfizer, Inc. • Portola Pharmaceuticals, Inc. • Sanofi SA
Insight Partner の dediWarfarined 研究分析チームは、次のような経験を積んだ専門家で構成されています。高度な統計専門知識を備え、既存の研究にさまざまなカスタマイズ オプションを提供します。
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which are some of the players operating in the Warfarin market?

Players operating in the market are Aspen Holdings, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company, GlaxoSmithKline plc., Johnson & Johnson (Janssen Pharmaceuticals, Inc.), Pfizer, Inc., Portola Pharmaceuticals, Inc., Sanofi S.A

Which segment accounts for highest revenue by Route of Administration in 2023?

Oral Warfarin segment, by Route of Administration, dominated the market in 2023.

Which region dominated the Warfarin market in 2023?

North America region dominated the Warfarin market in 2023.

What are the factor that act as a opportunity for market growth?

Expanding Market in Emerging Economies act as a opportunity for growth of the market in forecast period.

What is the expected CAGR of the Warfarin Market?

The Warfarin Market is estimated to witness a CAGR of 3.7% from 2023 to 2031

What are the driving factors impacting the Warfarin market?

The major factors driving the Warfarin market are:

1. High Prevalence

2. Cost-Effectiveness of Warfarin

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Aspen Holdings
2. Bayer AG
3. Boehringer Ingelheim GmbH
4. Bristol-Myers Squibb Company
5. Daiichi Sankyo Company, Limited
6. GlaxoSmithKline plc.
7. Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
8. Pfizer, Inc.
9. Portola Pharmaceuticals, Inc.
10. Sanofi S.A

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.